Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Biosenic Receives Key European Patent From EPO For Further Therapeutic Development

April 18 (Reuters) - Bone Therapeutics SA  BIOS.BR :
    * BIOSENIC RECEIVES KEY EUROPEAN PATENT FROM EPO, FOR
FURTHER
THERAPEUTIC DEVELOPMENT IN CANCER, INFECTIOUS AND IMMUNE
DISEASES

Source text for Eikon:  ID:nGNEby2kCl 
Further company coverage:  BIOS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Biosenic SA

See all news